Literature DB >> 2386133

Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy.

A S Yap1, W M Clouston, R H Mortimer, R F Drake.   

Abstract

We report a case of acromegaly diagnosed in the second trimester of pregnancy. Bromocriptine (7.5 mg per day) corrected visual field defects and suppressed prolactin secretion but did not reduce fasting growth hormone levels. We propose that suppression of physiologic lactotroph hyperplasia by bromocriptine may permit noninvasive management of pituitary adenomas during pregnancy.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2386133     DOI： 10.1016/0002-9378(90)91178-f

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Medical management of pituitary adenomas: the special case of management of the pregnant woman.

Authors:  Marcello Delano Bronstein; Luiz Roberto Salgado; Nina Rosa de Castro Musolino
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 2.  Pregnancy in acromegaly.

Authors:  Bashir A Laway
Journal:  Ther Adv Endocrinol Metab       Date:  2015-12       Impact factor: 3.565

Review 3.  Pregnancy and acromegaly: a review.

Authors:  Vicky Cheng; Charles Faiman; Laurence Kennedy; Fadi Khoury; Betul Hatipoglu; Robert Weil; Amir Hamrahian
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

4.  Acromegaly in pregnancy.

Authors:  T George Koshy; Simon Rajaratnam; Jiji Elizabeth Mathews; Vedantam Rajshekhar
Journal:  Indian J Endocrinol Metab       Date:  2012-11

5.  Pregnancy and pituitary disorders: Challenges in diagnosis and management.

Authors:  Bashir A Laway; Shahnaz A Mir
Journal:  Indian J Endocrinol Metab       Date:  2013-11

Review 6.  Pregnancy and acromegaly.

Authors:  Ammar Muhammad; Sebastian J Neggers; Aart J van der Lely
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.